{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "marketState": "REGULAR", "exchange": "PNK", "shortName": "NUO THERAPEUTICS INC", "longName": "Nuo Therapeutics, Inc.", "messageBoardId": "finmb_415042", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 2.0, "regularMarketChange": 0.0, "regularMarketTime": 1684165021, "regularMarketDayHigh": 2.0, "regularMarketDayRange": "2.0 - 2.0", "regularMarketDayLow": 2.0, "regularMarketVolume": 200, "regularMarketPreviousClose": 2.0, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Other OTC", "financialCurrency": "USD", "regularMarketOpen": 2.1, "averageDailyVolume3Month": 592, "averageDailyVolume10Day": 202, "fiftyTwoWeekLowChange": 1.55, "fiftyTwoWeekLowChangePercent": 3.4444444, "fiftyTwoWeekRange": "0.45 - 4.5", "fiftyTwoWeekHighChange": -2.5, "fiftyTwoWeekHighChangePercent": -0.5555556, "fiftyTwoWeekLow": 0.45, "fiftyTwoWeekHigh": 4.5, "earningsTimestamp": 1566244800, "earningsTimestampStart": 1597708800, "earningsTimestampEnd": 1598054400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.08, "sharesOutstanding": 41799000, "bookValue": 0.052, "fiftyDayAverage": 2.45, "fiftyDayAverageChange": -0.45000005, "fiftyDayAverageChangePercent": -0.18367349, "twoHundredDayAverage": 2.1459332, "twoHundredDayAverageChange": -0.14593315, "twoHundredDayAverageChangePercent": -0.06800452, "marketCap": 83598000, "priceToBook": 38.461536, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1508851800000, "priceHint": 4, "displayName": "Nuo Therapeutics", "symbol": "AURX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "8285 El Rio", "address2": "Suite 190", "city": "Houston", "state": "TX", "zip": "77054", "country": "United States", "phone": "346 396 4770", "website": "https://www.nuot.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was incorporated in 1998 and is based in Houston, Texas.", "fullTimeEmployees": 10, "companyOfficers": [{"maxAge": 1, "name": "Mr. David E. Jorden CPA", "age": 60, "title": "CEO, CFO, Sec. & Exec. Director", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": {"raw": 168750, "fmt": "168.75k", "longFmt": "168,750"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 591153, "fmt": "591.15k", "longFmt": "591,153"}}, {"maxAge": 1, "name": "Dr. Peter Anton Clausen Ph.D.", "age": 56, "title": "COO & Chief Scientific Officer", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": {"raw": 210000, "fmt": "210k", "longFmt": "210,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 541091, "fmt": "541.09k", "longFmt": "541,091"}}, {"maxAge": 1, "name": "Mr. Joseph  Del Guercio", "age": 50, "title": "Informal Board Advisor", "yearBorn": 1972, "fiscalYear": 2017, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}